Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA

British Journal of Cancer

Volumn 75, Issue 6, 1997, Pages 789-797

  Nilsson, O ^a   Peter, A ^a   Andersson, I ^a   Nilsson, K ^a   Grundstrom B ^a   Karlsson, B ^a  

^a Fujirebio Diagnostics Inc   (Sweden)

Author keywords

anti chymotrypsin; Epitope mapping; Free prostate specific antigen; Immunoassays; Prostate specific antigen; Prostate specific antigen in complex with

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; EPITOPE; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; EPITOPE MAPPING; FEMALE; HUMAN; IMMUNOASSAY; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031054124     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.142     Document Type: Article

References (41)

1. Akiyama K, Nakamura T, Iwanaga S and Hara M (1987) The chymotrypsin-like activity of human prostate-specific antigen, y-seminoprotein. FEBS Lett 255: 168-172
2. Belangcr A, Rong PM, Liu S, Lavoi L and Labric F (1993) Characterization and measurement of prostate-specific antigen using monoclonal antibodies. Clin Invest Hied 16:409-414
3. Bluestein B, Zhou A, Tewari P, Comerci C, Schubert W and Larsen FL (1992) Multi-site clinical evaluation of an automated chemiluminescent immuno-assay for prostate-specific antigen (ACS PSA). J Tumor Marker Oncol 7: 41-60
4. Christensson A ( 1993) Prostate-Specific Antigen. Enzyme Activity and Reactions with Extracellular Protease Inhibitors Thesis University of Lund
5. Christensson A, Laurell C-B and Lilja II (1990) Enzymatic activity of prostatespecific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 194: 755-763
6. Christensson A, Björk T, Nilsson O, Dahlén U, Matikainen M-T, Cockett ATK, Abrahamsson PA and Lilja II (1993) Serum prostate specific antigen complexed to a, antichymotrypsin as an indicator of prostate cancer. J Urol 150: 100-105
7. Chu TM, Kawinski E, Hibi N, Croghan G, Wiley J, Killian CS and Corral D (1989) Prostate-specific antigenic domain of human prostate specific identified with monoclonal antibodies. J Urol 141: 152-156
8. Graves HCB (1993) Standardization of immunoassays for prostate-specific antigen. A problem of prostate-specific antigen complexation or a problem of assay design? Cancer 72: 3141-3144
9. Graves HCB, Wehner N and Stamey TA (I990) Comparison of a polyclonal and monoclonal immunoaasy for PSA: need for an international antigen standard. J Urol144:1516-1522
10. Hemmila' I, Dakubu S, Mukkala VM, Siitari H and Lövgren T (1983) Europium as a label in time-resolved immunofluorometricc assays. Anal Biochem 137: 335-340
11. 1-antichymotrypsin. dm Client 39: 2098-2103
12. Lilja II (1993) Significance of different molecular forms of serum PSA Urol Clin N Am 20: 681-686
13. Lilja II (1985) A kallikrcin-like serine prolease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Imest 76: 1899-1903
14. Lilja H, Oldbring J, Rannevik G and Laurell C-B (1987) Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest 80:281-285
15. Lilja II, Christensson A, Dahlén U, Matikainen M-T, Nilsson O, Pettersson K and Lövgren T (1991) Prostate-specific antigen in serum occurs pre-dominantly in complex with ctj-antichymotrypsin. din Clicin 37: 1618-1625
16. Lilja H, Cockett ATK and Abrahamsson P-A (1992) Prostate-specific antigen predominantly in complex with cantichymotrypsin Cancer 70: 230-234
17. Lindolm L, Holmgren J, Svennerholm L, Fredman P, Nilsson O, Persson B, Myrvold II and Lagergard T (1983) Monoclonal antibodies against gastro-intestinal tumour-associated antigens isolated as monosialo-gangliosides. hit Arclis Allergy Appl Immunol 71: 178-181
18. Lundwall Å (1989) Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem Biophys Res Commun 161: 1151-1159
19. Lundwall Å and Lilja H (1987) Molecular cloning of human prostate-specific antigen cDNA. FEBS Lett 214: 317-322
20. Lövgren J, Piironen T, Övermo C, Dowell B, Karp M, Pettersson K, Lilja H and Lundvall A (1995) Production of recombinant PSA and HK2 and analysis of their immunological cross-reactivity. Biochem Biophys Res Comm 213: 888-895
21. Nilsson O, Dohlen U, Grundström B, Karlsson B and Nilsson K (1994a) Development of immunoassays specific for the different serological forms of PSA. In Current Tumor Diagnosis: Applications, Clinical Relevance. Research. Trends Klapdor R (ed), pp. 289-296 W Zuckswerdt: München
22. Nilsson O, Dahlén U and Karlsson B (19946) Free and total PSA in healthy subjects and in patients with benign and malignant prostatic disease. In Basic Research and Clinical Application in Human Tumor Immunology and Molecular Biology. Proceedings of the XXIInd Meeting of ISOBM, Groningen 1994, p. 319
23. Oesterling JE (1991) Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923
24. Paus E, Fossa SD, Nilsson O, ERI M and Börmer O (1995) The ralio of free to total PSA may be influenced by handling of serum samples. 8th International Hamburg Symposium On Tumor Markers
25. Pettersson K, Piironen T, Seppälä M, Liukkonen L, Christensson A, Matikainen MT, Suonpää M, Lövgren T and Lilja H (1995) Free and complexed prostatespecific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of F-PSA and PSAal-antichymotrypsin complex. Clin Chem 41: 1480-1488
26. Pettersson K, Piironen T, Karp M, Lövgren T, Dowell B, Lövgren J and Lilja H (1996) Novel, specific and sensitive immunoassay for hK2 measures low concentrations of serum hK2 compared to PSA. J Urol 155 (suppl.) 695A
27. Prestigiacomo AF and Stamey TA (1994) A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residua! cancer after radical prostatectomy. J Urol 152: 1515-1519
28. Prestigiacomo AF and Stamey TA (1995) Clinical usefulness of free and complexed PSA. ScandJClin Lab Invest (suppl.) 221: 32-34
29. Riegman PH, Vliestra RJ, Van Der Korput J, Romijn J and Trapman J (1989) Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem Biophys Res Comm 159: 95-102
30. Schedlich U, Bennetts B and Morris BJ (1987) Primary structure of a human glandular kallikrein gene. DM 6:429-437
31. Slota J, Prine B, Magic S, Dowell B and Huhn O (1994) Detection ofa circulating immune complex of PSA and IgG in a patient with benign prostatic hyperplasia and hypergammaglobulinemia In Basic Research and Clinical Application in Hitman Tumor Immunology and Molecular Biology, Proceedings of the XXIInd Meeting of ISOBM, Groningen 1994, p 312
32. Stamey TA, Prestigiacomo AF and Chen Z (1994) Standardization of immunoassays for prostate-specific antigen: a different view based on experimental observation. Cancer 74: 1662-1666
33. Stenman UH, Leinonen J, Alfthan H, Ranniko S, Tuhkanen K and Alfthan O (1991) A complex between prostate specific antigen and c-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assays of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226
34. Vessella RL (1993) Trends in immunoassays of prostate-specific antigen: serum complexes and ultrasensitivity. din Chem 39: 2035-2039
35. Vessella RL and Lange PH (1993) Issues in the assessment of PSA immunoassays. Urol Clin North Am 20: 607-619
36. Wang MC, Valenzuela LA, Murphy GPand Chu TM (1979) Purification of a human prostate specific antigen. Invest Urol 17: 159-163
37. Wang TJ, Hill T, Sokoloff R, Frankenne F, Wolfert R and Rittenhouse H (1994) Monoclonal antibody sandwich immunoassay to quanlitale F-PSA in benign prostate hyperplasia and prostate cancer. In Basic Research and Clinical Application in Human Tumor Immunology and Molecular Biology, Proceedings of the XXIInd Meeting oflSOBM, Groningen 1994, p 317
38. Watt KWK, Lee P-J, M'timkulu T, Chan W-P and Loor R ( 1986) Human prostatespecific antigen: structural and functional similarity with serine proteases. Proc Nail Acad Sei USA 83: 3166-3170
39. Wood WG, Van Der Sloot E and Bohle A (1991) The establishment and evaluation of luminiescent-labeled immunometric assays for prostate-specific antigen-a,antichymotrypsin complexes in serum. Eur J Clin Chcm Clin Biochem 39: 787-794
40. Yu H and Diamanidis EP(1993) Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin Chem 39: 2108-2114
41. Zhou A, Tewari PC, Bluestein BI, Caldwell GW, Larsen FL (1993) Multiple forms of prostate-specific antigen in scrum: differences in immuno-recognition by monoclonal and polyclonal assays. Clin Chem 39:2483-2491